We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

25 hedge funds and large institutions have $12.9M invested in Apollo Endosurgery, Inc. in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

14% more funds holding

Funds holding: 2225 (+3)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

10% less capital invested

Capital invested by funds: $14.3M → $12.9M (-$1.39M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $34K

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
7
Reduced
7
Closed
2
Calls
Puts
$34K
Net Calls
-$34K
Net Calls Change
+$32K

APEN Hedge Fund Activity: Q4 2014 in Review

25 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2014, worth a combined $12.9M — down 9.7% from $14.3M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new APEN positions and 2 closed out — a net gain of 3 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Franklin Resources, adding an estimated $2.25M. The largest seller was Sabby Management, cutting an estimated $1.1M.

  • 25 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2014, up from 22 in Q3 2014.
  • Funds reported $12.9M of Apollo Endosurgery, Inc. stock for Q4 2014, down 9.7% quarter-over-quarter.
  • 5 funds opened new Apollo Endosurgery, Inc. positions in Q4 2014 and 2 closed out, a net change of +3 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2014 was Franklin Resources, an estimated $2.25M added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2014 was Sabby Management, an estimated $1.1M sold.

Based on aggregated 13F filings for Q4 2014.